Hello! You're looking at a policy document report on Overton

We track government policy, guidelines, think tank research, working papers and more to help our customers see the impact and influence of their work.

If you fund, produce or manage research or work to influence policy, we'd love to talk. Learn more on our homepage.

All research cited by this document (explore the cited policy documents)

Centers for Disease Control and Prevention (CDC)
CDC has updated its guidance on what specimens to collect when testing for COVID-19. The latest guidance is available online at Evaluating and Testing Persons for Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html
Centers for Disease Control and Prevention (CDC)
This interim guidance is based on what is currently known about COVID-19. The Centers for Disease Control and Prevention (CDC) will update this interim guidance as needed and as additional information becomes available. https://www.cdc.gov/coronavirus/2019-ncov/about/index.html
In addition to postmortem specimens, submission of any remaining clinical specimens (e.g., NP swab, OP swab, sputu serum, stool) that may have been collected prior to death is recommended. Please refer to Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens from Persons Under Investigation (PUIs) for Coronavirus Disease 2019 (COVID-19) for more information. https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html
Implementing proper biosafety and infection control practices is critical when collecting specimens. Please refer to Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19) for additional information. https://www.cdc.gov/coronavirus/2019-nCoV/lab/lab-biosafety-guidelines.html